Skip to main content

Full Committee Hearing: Johnson & Johnson's Recall of Children's Tylenol and other Pediatric Medicines

Meeting Status:
Scheduled
Date:
Location:
2154 Rayburn House Office Building

On Thursday, May 26, 2010, the House Committee on Oversight and Government Reform held a hearing entitled, “Johnson and Johnson’s Recall of Children’s Tylenol and Other Children’s Medicines.” The hearing examined the circumstances surrounding the voluntary recall of popular infant and children’s medicines produced by Johnson & Johnson/McNeil Consumer Healthcare.

On May 5, 2010, Chairman Towns and Ranking Member Darrell Issa (R-CA) opened the committee’s investigation into the circumstances surrounding the voluntary recall of widely used pediatric medications.Johnson & Johnson recalled 6 million bottles from over 40 different types of medicines including brands such as Children’s Tylenol, Infants’ Tylenol, Children’s Motrin, and Children’s Benadryl.

 

Witnesses

Witnesses

Panel I

Dr. Joshua M. Sharfstein
Principal Deputy Commissioner
U.S. Food & Drug Administration

Accompanied by:

Ms. Deborah M. Autor
Director of the Office of Compliance
Center for Drug Evaluation and Research
Food and Drug Administration; and

Mr. Michael A. Chappell
Acting Associate Commissioner for Regulatory Affairs
Food and Drug Administration

Panel II

Ms. Colleen Goggins
Worldwide Chairman
Johnson & Johnson Consumer Group

Issues: Health Care